MYGN · Forms 3, 4, 5
Insider trades at MYRIAD GENETICS INC
No open-market insider buys or sells at MYRIAD GENETICS INC in the last 90 days; 6 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for MYRIAD GENETICS INC (MYGN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Benjamin Richard Wheeler | Chief Financial Officer | Tax withholding | 2,555 | $4.01 | $10K | Form 4 | |
| Brian J Donnelly | Chief Commercial Officer | Options or other derivatives | Form 4 | ||||
| Vishal Sikri | EVP, Commercial | Became an insider (Form 3) | Form 3 | ||||
| Vishal Sikri | EVP, Commercial | Award | 257,731 | Form 4 | |||
| Jennifer Lynne Fox | Chief Legal Officer | Tax withholding | 4,398 | $3.23 | $14K | Form 4 | |
| Benjamin Richard Wheeler | Chief Financial Officer | Tax withholding | 8,761 | $3.03 | $27K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.